The affordable biocompatible calcium-phosphate bone substitute

The affordable biocompatible calcium-phosphate bone substitute

BIOCERA-VET® GRANULES is a synthetic bone substitute made of calcium-deficient apatite (CDA) crystals chemically close to the mineral composition of the natural bone.

BIOCERA-VET GRANULES:

GET OUR BIOCERA-VET GRANULES PRODUCTS

DO YOU WANT TO KNOW MORE?

Watch the testimonial of Dr RAGETLY about the use of BIOCERA-VET in bone surgery.

Dr RAGETLY, DVM, PhD, Dipl. ACVS, Dipl. ECVS, Surgery specialist – CHV Frégis, France

BIOCERA-VET : PROVEN EFFICACY AND SAFETY2

IN ARTHRODESIS, BIOCERA-VET SHOWS A COMPARABLE BONE FUSION3 AND LESS COMPLICATIONS

image16

(2) “Efficacy and safety assessment of a self-setting bone substitute (α-TCP) as efficient alternative to autograft. Ragetly et al. 2022.” Best Poster Presentation at the VOS (Veterinary Orthopedic Society)
(3) Bone Fusion was assessed by a blinded independent radiological analysis by a qualified orthopedic surgeon using a numerical rating scale rating from 0-3 as described by Michael et al., 2003 and Ree et al. 2016

DO YOU PRACTICE ORTHOPEDIC SURGERIES?

Get in touch with us for more information about BIOCERA-VET’s advantages and indications

Fill in the form to receive our latest clinical data and information about our new products

"*" indicates required fields

WHY BIOCERA-VET BONE SURGERY?

preparation-bioceravet

Easy and intuitive preparation, high injectability

temp-global-bioceravet

Reduced surgery time

temps-bioceravet

Fast-setting and mechanical strength

intégration-bioceravet

Excellent osteointegration

accélération-bioceravet

Accelerated bone consolidation

diminution-bioceravet

Reduced co-morbidities and complications (compared to autografts)

HOW TO USE

“BIOCERA-VET induces bone fusion thanks to its interesting properties of osteoconduction and osteointegration. It has real advantages for the veterinary surgeon allowing him to have an alternative to autograft, with less complications while saving significant surgical time.”

Dr Guillaume RAGETLY, DVM, PhD, Dipl. ACVS, Dipl. ECVS
Head of Department of Surgery at CHV Frégis (France)